These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28137213)

  • 21. QSAR Modeling of COX -2 Inhibitory Activity of Some Dihydropyridine and Hydroquinoline Derivatives Using Multiple Linear Regression (MLR) Method.
    Akbari S; Zebardast T; Zarghi A; Hajimahdi Z
    Iran J Pharm Res; 2017; 16(2):525-532. PubMed ID: 28979307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
    Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
    J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
    Ahmadinejad N; Shafiei F
    Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors.
    Sirisha K; Shekhar MC; Umasankar K; Mahendar P; Sadanandam A; Achaiah G; Reddy VM
    Bioorg Med Chem; 2011 May; 19(10):3249-54. PubMed ID: 21530277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR and classification study of 1,4-dihydropyridine calcium channel antagonists based on least squares support vector machines.
    Yao X; Liu H; Zhang R; Liu M; Hu Z; Panaye A; Doucet JP; Fan B
    Mol Pharm; 2005; 2(5):348-56. PubMed ID: 16196487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors.
    Längle D; Marquardt V; Heider E; Vigante B; Duburs G; Luntena I; Flötgen D; Golz C; Strohmann C; Koch O; Schade D
    Eur J Med Chem; 2015 May; 95():249-66. PubMed ID: 25817775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dynamics simulation and molecular docking studies of 1,4-Dihydropyridines as P-glycoprotein's allosteric inhibitors.
    Shahraki O; Zargari F; Edraki N; Khoshneviszadeh M; Firuzi O; Miri R
    J Biomol Struct Dyn; 2018 Jan; 36(1):112-125. PubMed ID: 27981890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
    Murahari M; Kharkar PS; Lonikar N; Mayur YC
    Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 1,4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent.
    Mollazadeh S; Moosavi F; Hadizadeh F; Seifi M; Behravan J; Iman M
    Recent Pat Anticancer Drug Discov; 2018; 13(2):255-264. PubMed ID: 29468983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of ab initio theory to QSAR study of 1,4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures.
    Hemmateenejad B; Safarpour MA; Miri R; Taghavi F
    J Comput Chem; 2004 Sep; 25(12):1495-503. PubMed ID: 15224393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent.
    Viradiya D; Mirza S; Shaikh F; Kakadiya R; Rathod A; Jain N; Rawal R; Shah A
    Anticancer Agents Med Chem; 2017; 17(7):1003-1013. PubMed ID: 27924733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDR.
    Miri R; Mehdipour A
    Bioorg Med Chem; 2008 Sep; 16(18):8329-34. PubMed ID: 18701304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3,5-dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.
    Kawase M; Shah A; Gaveriya H; Motohashi N; Sakagami H; Varga A; Molnár J
    Bioorg Med Chem; 2002 Apr; 10(4):1051-5. PubMed ID: 11836114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a neural net-based QSAR algorithm (PCANN) with Hologram- and multiple linear regression-based QSAR approaches: application to 1,4-dihydropyridine-based calcium channel antagonists.
    Viswanadhan VN; Mueller GA; Basak SC; Weinstein JN
    J Chem Inf Comput Sci; 2001; 41(3):505-11. PubMed ID: 11410024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.
    Izadpanah E; Riahi S; Abbasi-Radmoghaddam Z; Gharaghani S; Mohammadi-Khanaposhtanai M
    Mol Divers; 2021 Aug; 25(3):1811-1825. PubMed ID: 33565001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
    Noolvi MN; Patel HM; Kamboj S
    Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.